Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor

Molecular Pharmacology

Volumn 60, Issue 6, 2001, Pages 1181-1188

  Bunzow, J R ^a   Sonders, M S ^a   Arttamangkul, S ^a   Harrison, L M ^a   Zhang, G ^a   Quigley, D I ^a   Darland, T ^a   Suchland, K L ^a   Pasumamula, S ^a   Kennedy, J L ^a   Olson, S B ^a   Magenis, R E ^a   Amara, S G ^a   Grandy, D K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMINE RECEPTOR AGONIST; AMPHETAMINE; LYSERGIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHROMOSOME 6Q; DRUG EFFECT; DRUG RECEPTOR BINDING; GENE ISOLATION; HUMAN; HUMAN CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

EID: 0035206793     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.6.1181     Document Type: Article

References (40)

1. Neurotransmitter transporters as molecular targets for addictive drugs
2. Chemical structure and sympathomimetic action of amines
3. Antagonism of an indirectly acting agonist: Block by propranolol and sotalol of the action of tyramine on rat heart
4. Trace amines: Identification of a family of mammalian G protein-coupled receptors
5. Biosynthesis and excretion of meta and para tyramine in the rat
6. Some aspects of basic psychopharmacology: The trace amines
7. The monoamine oxidase inhibitor-tyramine interaction
8. Amphetamine derivative fatalities in South Australia-is "ecstasy" the culprit?
9. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees
10. Metabolism of amphetamine and other arylisopropylamines
11. The pharmacology of Parkinson's disease: Basic aspects and recent advances
12. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia
13. A human D1 dopamine receptor gene is located on chromosome 5 at q35.1 and identifies an EcoRI RFLP
14. Expression in animal cells of the 5-HT1A receptor by a vaccinia virus vector system
15. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases
16. Effects of the noradrenaline metabolites on the adrenergic receptors
17. Beta-phenylethylamine (PEA): An endogenous anxiogen? Three series of experimental data
18. Cloning and characterization of additional members of the G protein-coupled receptor family
19. Multicenter linkage study of schizophrenia candidate regions on chromosome 5q, 6q, 10p, and 13 q: Schizophrenia linkage collaborative group III
20. 5.42 in ligand binding to and activation of the beta 2-adrenergic receptor
21. Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors
22. Indoleamine and the phenethylamine hallucinogens: Mechanisms of psychotomimetic action
23. Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q
24. The trace amine tyramine is essential for sensitization to cocaine in Drosophila
25. Platelet monoamine oxidase activity and plasma levels of non-catecholic phenylethylamines in insulin-dependent diabetic subjects
26. Molecular genetics of schizophrenia
27. Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells
28. Psychophysiological aspects of amphetamine-methamphetamine abuse
29. 2-Phenylethylamine: A modulator of catecholamine transmission in the mammalian central nervous system?
30. Protein kinases that phosphorylate activated G protein-coupled receptors
31. Neurotoxic amphetamine analogues: Effects in monkeys and implications for humans
32. 3H-noradrenaline by p- and m-tyramines and -octopamines, and the effect of deuterium substitution in alpha-position
33. Brain dopamine receptors
34. Amphetamine: Effects on catecholamine systems and behavior
35. Self-administration of the endogenous trace amines β-phenylethylamine N-methylphenylethylamine and phenylethanolamine in dogs
36. Biosynthesis and metabolism of endogenous tyramine and its normal presence in sympathetic nerves
37. Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: Utility of 3-methoxytyramine measurements
38. Cloning of a putative human neurotransmitter receptor expressed in skeletal muscle and brain